Placebo: The best pill of all

CNS Spectrums

Volumn 10, Issue 6, 2005, Pages 440-442

  Stein, Dan J ^a,b   Mayberg, Helen ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF FLORIDA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY DISORDER; CASE REPORT; CLINICAL FEATURE; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG FORMULATION; DRUG RESEARCH; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INFORMED CONSENT; MALE; NAUSEA; NEUROBIOLOGY; NEUROCHEMISTRY; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; SHORT SURVEY; SOCIAL PHOBIA; SYMPTOM; TEACHING HOSPITAL; TREATMENT OUTCOME;

EID: 21644450885     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900023117     Document Type: Short Survey

References (38)

1. Leber P. The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Biol Psychiatry. 2000;47:699-706.
2. Khan A, Khan S, Brown WA. Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol. 2002;5:193-197.
3. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with new randomized trials comparing placebo with no treatment. J Intern Med 2004;256:91-100.
4. McDonald CJ, Mazzuca SA, McCabe GP Jr. How much of the placebo 'effect' is really statistical regression? Stat Med. 1983;2:417-427.
5. Brody H. Three perspectives on the placebo response: Expectancy, conditioning, and meaning. Adv Mind Body Med. 2000;16:211-232.
6. Kirsch I. Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd. Psychol Bull. 2004;130:341-343.
7. Charney DS, Nemeroff CB, Lewis L, et al. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry. 2002;59:262-270.
8. Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004;1:CD003012.
9. Benedetti F, Amanzio M. The neurobiology of placebo analgesia: from endogenous upioids to cholecystokinin. Prog Neurobiol. 1997;51:109-125.
10. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science, 2004;303:1162-1167.
11. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanaromy of the placebo effect. Am J Psychiatry. 2002;159;728-737.
12. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed patients during treatment with placebo. Am J Psychiatry. 2002;159;122-129.
13. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science. 2002;295:1737-1740.
14. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978;2;654-657.
15. Amanzio M, Polio A, Maggi G, Benadetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001;90:205-215.
16. de la Fuente-Fernandez R, Phillips AG, Zamburlini MJ, et al. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res. 2002;136;359-363.
17. de la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release; mechanism of the placebo effect in Parkinson's disease. Science. 2001;293;1164-1166.
18. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003;299:1898-1902.
19. Benedetti F, Colloca L, Tone E, et al. Placebo-responsive Parkinson patients showed decreased activity in single neurons of subthalamic nucleus. Nat Neurosci. 2004;7:587-588.
20. Shapiro AK, Shapiro E. The Powerful Placebo: From Ancient Priest to Modern Physician. Baltimore, MD: Johns Hopkins University Press; 2001.
21. Guess HA, Kleinman A, Kusek JW, Engel LW. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London: BMJ Books; 2002.
22. Brody H. Placebos and the Philosophy of Medecine: Clinical, Conceptual, and Ethical Issues. Chicago, IL: University of Chicago Press; 1980.
23. Harrington A. The Placebo Effect: An Interdisciplinary Collaboration. Cambridge, Mass: Harvard University Press; 1999.
24. White L, Tursky B, Schwartz GE. Placebo: Theory, Research, and Mechanisms. New York, NY: Guilford Press; 1985.
25. Moerman DE, Meaning, Medicine and the 'Placebo Effect.' Cambridge, Mass: Cambridge University Press; 2002.
26. Bendesky A, Sonabend AM. On Schlepfuss' path: the placebo response in human evolution. Med Hypotheses. 2005;64:414-416.
27. Evans D. Placebo: The Belief Effect. New York, NY: HarperCollins; 2003.
28. McMillan FD. The placebo effect in animals. J Am Vet Med Assoc. 1999;215:992-999.
29. Barksy AJ, Saintfort R, Rogers MP, Borus, JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622-627.
30. Posternak MA, Zimmerman M, Keitner GI, Miller IW. A reevaluation of the exclusion criteria used in antidepressant efficacy trials.Am J Psychiatry. 2002;159:191-200.
31. Quitkin FM, Raskin JG, Markowitz JM, et al. Use of pattern analysis to identify-true drug response: a replication. Arch Gen Psychiatry. 1987;44:259-264.
32. Nierenberg AA, Quitkin FM, Kremer C, et al. Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse. Neuropsychophamacology. 2004;29:l012-1018.
33. Zimbroff DL. Patient rater education of expectations in clinical trials (PREECT). J Clin Psychopharmacol. 2001;21:251-252.
34. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA, 2002;287:1840-1847.
35. Rickels K. Non-Specific Factors in Drug Therapy. Springfield, IL; Charles C. Thomas: 1968.
36. Di Blasi Z, Kaptchuk TJ, Weinman J, Kleijnen J. Informing participants of allocation to placebo at trial closure: postal survey. BMJ. 2002;325:1329.
37. Kirsch I, Weixel LJ. Double-blind versus deceptive administration of a placebo. Behav Neurosci. 1988;102:319-323.
38. Kent MA, Camfield CS, Camfield PR. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med. 1999;153:1292-1296.